Estéfany Lopes Lemes Do Prado

Estéfany Lopes Lemes Do Prado

Auto-generated profile, based on publicly available information

Estéfany Lopes Lemes Do Prado

Department of Dental Materials and Prosthodontics, School of Dentistry, Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), Araçatuba, SP, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Brazilian Journal of Biology
Verified
Journal Article
Open access
LPL. V. Pinheiro
L. V. Pinheiro
EPE. L. L. Prado
E. L. L. Prado
MJM. S. Januzzi
M. S. Januzzi
CIC. T. M. I. Issa
C. T. M. I. Issa
KAK. L. G. D. Albuquerque
K. L. G. D. Albuquerque
KTK. H. L. Turcio
K. H. L. Turcio
Medicinal cannabis has been the subject of extensive research, with recent studies demonstrating its potential in managing chronic pain and enhancing quality of life. This case report examines the use of medicinal cannabis in a patient treated at the School of Dentistry of Araçatuba (FOA-UNESP). The patient, a 28-year-old female with no comorbidities, presented with chronic muscular TMD and reported poor sleep quality. Full-spectrum cannabis oil (1:1 ratio of THC to CBD), was prescribed for a period of 60 days, with a maximum dosage of 10 drops per day. Pain intensity was measured using the Visual Analog Scale (VAS), while sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Evaluations were conducted at three intervals: baseline, day 30, and day 60. To ensure patient safety, pre- and post-treatment blood tests were performed, and dosage adjustments were made every three days under the supervision of the study’s medical team. The results revealed significant improvements in pain management, with the patient’s orofacial pain score decreasing from 7 to 3 on the NRS. Additionally, sleep quality improved, as reflected by a lower PSQI score (global sleep quality at level 6 at the end), indicating more restorative sleep. Throughout the treatment period, the patient experienced mild side effects, including drowsiness and gastrointestinal discomfort, which were effectively managed through dosage modifications. In conclusion, full-spectrum cannabis oil shows promise as a therapeutic strategy for managing orofacial pain and improving sleep quality, providing significant relief in conditions where other interventions are ineffective or poorly tolerated. Further research is warranted to better understand the therapeutic mechanisms and potential side effects of medicinal cannabis in the management of chronic pain and related conditions.

25 January 2026 in Brazilian Journal of Oncology
Verified
Journal Article
Open access
PDF file
MJMarcella Santos Januzzi
Marcella Santos Januzzi
DSDaniela Micheline Dos Santos
Daniela Micheline Dos Santos
LPLucas Tavares Piacenza
Lucas Tavares Piacenza
LPLarissa Iceri Perez
Larissa Iceri Perez
LPLarissa Viana Pinheiro
Larissa Viana Pinheiro
KTKarina Helga Leal Turcio
Karina Helga Leal Turcio
The treatment of head and neck cancer can significantly impair patients' quality of life, leading to oral and sensorineural complications. This study aimed to explore whether sensory alterations are primarily associated with tumor presence or with the effects of oncologic treatment by longitudinally assessing spontaneous orofacial pain and provoked muscle pain - in a case series of seven patients diagnosed with head and neck cancer undergoing oncologic treatment. Patients were selected from the Oral Oncology Center (COB) of the School of Dentistry at Universidade Estadual Paulista “Júlio de Mesquita Filho”. Assessments were conducted at 5 time points: baseline (T0), 30 to 45 days post-surgery (T1), one-week post-chemotherapy (T2), during radiotherapy (T3), and one-week post-radiotherapy (T4). Sensory function was analyzed through spontaneous pain measured by the Numeric Rating Scale (NRS) from 0 to 10, and provoked pain assessed via palpometry using 1 kg pressure and algometry tests on the masseter, temporalis, and sternocleidomastoid muscles. Only one patient (case 1) reported pain at T0, while two patients (cases 3 and 4) reported pain related to radiotherapy. Provoked muscle pain was highest at T0, particularly in cases 1, 4, and 7, but did not correlate with algometry pain thresholds. This case series indicates that sensory function may be affected by both tumor presence and oncologic treatment in a subset of patients.